UCSF - Emmanuelle Waubant, M.D.
Professor of Neurology at the University of California, San Francisco (UCSF)
Director of MS Fellowship Program and the Regional Pediatric MS Center at UCSF
Nancy Davis Medical Director since 2001
Emmanuelle L. Waubant, MD, PhD, FAAN, is currently Professor of Neurology at the University of California, San Francisco (UCSF). She directs the MS Fellowship Program and the Regional Pediatric MS Center at UCSF. Dr. Waubant has also served as the Nancy Davis Medical Director since 2001.
Dr. Waubant received her medical degree at the University of Lille, France. She did her residency in neurology and served two years as junior faculty in the Neurology Department of Toulouse, Purpan University, France. She continued her training as a neuroimmunology fellow in Dr Stephen Hauser’s UCSF laboratory, focusing on enzymes and their inhibitors that regulate the migration of immune cells to the brain. Dr. Waubant later returned at the UCSF MS Center as a clinical research fellow. During that 3-year period, she applied her basic science findings to the study of multiple sclerosis (MS) in humans. After completing her research training at the UCSF MS center, Dr. Waubant returned to France to lead a clinical research center at Salpetriere Hospital in Paris for 2 years and returned to the UCSF MS center where she has been a faculty since September 2001.
Dr. Waubant serves on the clinical care and fellowship programs committees of the National Multiple Sclerosis Society and on the advisory board of the Society’s Northern California Chapter. She is the principal investigator on several clinical trials of promising agents for MS that she has designed. She also directs several translational research projects.
Dr. Waubant’s specific interests include the translation of promising agents from the bench to the bedside, understanding factors that predict the response to MS therapies, and risk factors for pediatric MS susceptibility and disease modification. Currently, she is the lead investigator for a neuroprotection study of riluzole in early relapsing-remitting MS supported by the National MS Society, and is the recipient of a large NIH grant to study environmental and genetic risk factors in pediatric MS.